Key Insights

Highlights

Success Rate

60% trial completion

Treatment Research

7 treatments under study, led by Measurement Of Resistance Through Forced Oscillations And Continuous Measurement Of Ventilation And Inspiratory Capacity During Tm6

Research Leaders

7 sponsors active, led by Hospices Civils de Lyon

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

2 terminated out of 8 trials

Success Rate

60.0%

-26.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

60% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3
Recruiting2
Terminated2
Unknown1

Trial Success Rate

60.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Measurement Of Resistance Through Forced Oscillations And Continuous Measurement Of Ventilation And Inspiratory Capacity During Tm61
  • Intimate Quality Of Life Questionnaire1
  • Multimodal Ntm Diagnostic Including Pcr Wgs Culture1
  • Self Administrated Questionnaire1
  • Usual Sport Activity1

Active Sponsors

  • Hospices Civils de Lyon2
  • University Hospital, Grenoble2
  • Vaincre la Mucoviscidose2
  • Research Center Borstel1
  • University Hospital, Tours1

Top Investigators

Related Conditions

  • Cystic Fibrosis Cf2
  • Condensate Of Exhaled Air1
  • Cystic Fibrosis1
  • Nontuberculous Mycobacteria1
  • Pulmonary Insufficiency1

Activity Timeline